A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study)-Reference-Cited by-同舟云学术

A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study)

Published:2022-05 Issue:5 Volume:36 Page:108188
ISSN:1056-8727
Container-title:Journal of Diabetes and its Complications
language:en
Short-container-title:Journal of Diabetes and its Complications

Author:

Loganathan Jayasree,Cohen Adam C.,Kaloupis Georgia M.,Harris Carolyn,Chronopoulos Andriana,James Vanessa,Hamilton Justin,Green Sarah,Wallis Andrew,Morgan Susan,Dauer Raymond,Gilfillan Christopher,Dear Anthony E.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference27 articles.

1. Incretin hormones and type 2 diabetes-mechanistic insights and therapeutic approaches;Boer;Biology (Basel),2020

2. A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model;Gaspari;Diab Vas Dis Res,2011

3. The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an apoE-/- mouse model;Gaspari;Diab Vasc Dis Res,2013

4. Liraglutide and cardiovascular outcomes in type 2 diabetes;Marso;N Engl J Med,2016

5. Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease;Serebruany;Thromb Haemost,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon‐like peptide‐1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta‐analysis and meta‐regression;Diabetes, Obesity and Metabolism;2024-03-20

2. Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression;2024-01-30

3. Glucagon-like Peptide-1 Receptor Pathway Attenuates Platelet Activation in Aspirin-Exacerbated Respiratory Disease;The Journal of Immunology;2023-10-23

4. Incretins and cardiovascular disease: to the heart of type 2 diabetes?;Diabetologia;2023-08-05

5. The expanding incretin universe: from basic biology to clinical translation;Diabetologia;2023-03-28